Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Kim Kardashian post prompts FDA warning letter

The agency says her social media post violates drug-promotion rules.

Kim Kardashian's social media posts promoting a prescription drug to treat morning sickness, has prompted the FDA to send a warning letter to the company who markets Diclegis.

The letter warns Duchesnay that the social media posts on the celebrity's various accounts violates the agency's drug promotion rules, according to the Associated Press.

Although the post links to the company website, which has the FDA-required labeling information, the agency says it's not enough and fails to list the possible side effects of the drug.

The agency also specifically notes in the letter that the post does not warn that Diclegis is not approved for women with a form of prolonged vomiting that causes dehydration.

Kardashian's post talks about battling nausea during her pregnancy – trying everything to help it without any positive results until she started taking Diclegis.

This is not the first time the company has come under fire by the FDA. According to the letter, they sent a letter to doctors without including the risk information, which prompted a similar letter in 2013.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging